Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.
暂无分享,去创建一个
James Y. Dai | P. Schrotz-King | H. Brenner | J. Chang-Claude | M. Hoffmeister | J. Potter | S. Gruber | S. Larsson | A. Wolk | M. Woods | G. Giles | J. Hopper | A. Joshi | D. Easton | G. Rennert | L. Le Marchand | D. Albanes | S. Weinstein | E. Giovannucci | S. Berndt | R. Milne | V. Moreno | G. Casey | A. Lindblom | V. Arndt | C. Stegmaier | A. Wu | P. Pharoah | P. Newcomb | U. Peters | S. Ogino | M. Jenkins | L. Hsu | E. White | R. Schoen | M. Slattery | M. Cotterchio | W. Grady | D. Buchanan | J. Lampe | C. Schafmayer | Katja Butterbach | B. Caan | M. Song | S. Bézieau | P. Campbell | H. Rennert | F. Lejbkowicz | M. Pinchev | W. Saliba | Li Li | V. Martín | Xiaoliang Wang | Zhengyi Chen | Kenneth Offitt | A. Chan | M. Jenkins | A. Wu | L. Hsu
[1] S. Vansteelandt,et al. Survivor bias in Mendelian randomization analysis. , 2018, Biostatistics.
[2] G. Davey Smith,et al. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.
[3] E. Riboli,et al. Association of CRP genetic variants with blood concentrations of C‐reactive protein and colorectal cancer risk , 2015, International journal of cancer.
[4] Tao Xi,et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis , 2014, Cancer Causes & Control.
[5] Eric J Tchetgen Tchetgen,et al. Methodological Challenges in Mendelian Randomization , 2014, Epidemiology.
[6] C. Carty,et al. Multiancestral Analysis of Inflammation-Related Genetic Variants and C-Reactive Protein in the Population Architecture Using Genomics and Epidemiology Study , 2014, Circulation. Cardiovascular genetics.
[7] S. Burgess. Sample size and power calculations in Mendelian randomization with a single instrumental variable and a binary outcome , 2014, International journal of epidemiology.
[8] C. Iacobuzio-Donahue,et al. The association between circulating high-sensitivity C-reactive protein concentration and pathologic measures of colonic inflammation , 2014, Cancer Causes & Control.
[9] A. Butterworth,et al. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.
[10] J. Pankow,et al. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study , 2013, Cancer Causes and Control.
[11] E. Giovannucci,et al. A prospective study of plasma inflammatory markers and risk of colorectal cancer in men , 2013, British Journal of Cancer.
[12] Simon G. Coetzee,et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. , 2013, Gastroenterology.
[13] Mathieu Lemire,et al. Material Supplementary Cited Articles E-mail Alerts Characterization of Gene–environment Interactions for Colorectal Cancer Susceptibility Loci American Association for Cancer Research , 2022 .
[14] C. Carlson,et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk , 2011, Human Genetics.
[15] M. Zhu,et al. Meta‐analysis: Circulating adiponectin levels and risk of colorectal cancer and adenoma , 2011, Journal of digestive diseases.
[16] C. Ulrich,et al. Genetic variation in C‐reactive protein in relation to colon and rectal cancer risk and survival , 2011, International journal of cancer.
[17] S. Thompson,et al. Avoiding bias from weak instruments in Mendelian randomization studies. , 2011, International journal of epidemiology.
[18] P. Elliott,et al. Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.
[19] J. Danesh,et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data , 2011, BMJ : British Medical Journal.
[20] V. Salomaa,et al. C-reactive protein-associated genetic variants and cancer risk: findings from FINRISK 1992, FINRISK 1997 and Health 2000 studies. , 2011, European journal of cancer.
[21] S. Bojesen,et al. C-reactive protein and the risk of cancer: a mendelian randomization study. , 2010, Journal of the National Cancer Institute.
[22] S. Itzkowitz,et al. Colorectal cancer in inflammatory bowel disease. , 2008, Gut and liver.
[23] T. Erlinger,et al. C‐reactive protein and colorectal cancer risk: A systematic review of prospective studies , 2008, International journal of cancer.
[24] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[25] George Davey Smith,et al. Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.
[26] Christopher F. Baum,et al. Enhanced Routines for Instrumental Variables/Generalized Method of Moments Estimation and Testing , 2007 .
[27] John D Potter,et al. Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.
[28] Steven Gallinger,et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.
[29] A. Hofman,et al. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] C. Franceschi,et al. Inflamm-aging, cytokines and aging: state of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. , 2006, Current pharmaceutical design.
[31] H. Cai,et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin , 2006, Nature Network Boston.
[32] K. Prasad. C-reactive protein (CRP)-lowering agents. , 2006, Cardiovascular drug reviews.
[33] P. Whincup,et al. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. , 2005, European heart journal.
[34] G. Hansson. Inflammation, atherosclerosis, and coronary artery disease. , 2005, The New England journal of medicine.
[35] H. Schreiber,et al. Inflammation as a tumor promoter in cancer induction. , 2004, Seminars in cancer biology.
[36] S. Rubin,et al. Physical Activity, Exercise, and Inflammatory Markers in Older Adults: Findings from The Health, Aging and Body Composition Study , 2004, Journal of the American Geriatrics Society.
[37] S. Itzkowitz,et al. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. , 2004, American journal of physiology. Gastrointestinal and liver physiology.
[38] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[39] Jonathan H. Wright,et al. A Survey of Weak Instruments and Weak Identification in Generalized Method of Moments , 2002 .
[40] N. Rifai,et al. C-reactive protein and cardiovascular disease: a review of risk prediction and interventions. , 2002, Clinica chimica acta; international journal of clinical chemistry.
[41] M. Cormican,et al. The acute phase response in breast carcinoma. , 2002, Anticancer research.
[42] R Doll,et al. Uncovering the effects of smoking: historical perspective , 1998, Statistical methods in medical research.